Variation of normal protein could be key to resistance to common...

Courtesy EurekAlert! - Cancer  Tue, 08/26/2008 - 23:00

(University of California - San Diego) Researchers at the Moores Cancer Center at the University of California, San Diego, in La Jolla have found evidence explaining why a common chemotherapy drug, cisplatin, may not always work for every cancer patient.

They have shown that when a variant version of a key protein that normally causes cell death is active, patients may be resistant to the cancer-killing drug.

Tags:

 

More related items

UC San Diego announces collaboration with Johnson & Johnson...
(University of California - San Diego) University of California, San Diego Health Sciences leaders have announced that they have executed a formal...

Cancer drugs my build and not tear down blood vessels
(University of California - San Diego) Scientists have thought that one way to foil a tumor from generating blood vessels to feed its growth -- a...

Tumors grow faster without blood-supply promoting molecule
(University of California - San Diego) Dense networks of blood vessels thought to spur cancer's growth could actually hinder rather than promote...

Moores UCSD Cancer Center studying novel leukemia vaccine for...
(University of California - San Diego) Researchers at the Moores Cancer Center at the University of California, San Diego are conducting clinical...

Just Do It: How One Couple Turned Off the TV and Turned On...
Outside of her family and close friends, Annie had not mentioned the sexathon to anybody, which probably was the best way to go. I, however, had...

Lovely by Sarah Jessica Parker Perfume for Women
New in factory retail box .

A Healthy Horse the Natural Way: A Horse Owner's Guide to Using...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
health-fitness.marc8.com